Xenetic Biosciences XBIO
NASDAQ XBIO
$2.23 -0.09 (-3.88%)
As of: Oct 1, 2026 · 3:59 PM EDT

Xenetic Biosciences (XBIO) Non Operating Income (2014 - 2026)

Updated

Xenetic Biosciences' Non Operating Income came in at $41,995 for Q2 2026, up 17.6% from $35,709 a year earlier but down 8.2% from the prior quarter.

Analysis

Xenetic Biosciences (XBIO) Non Operating Income (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Xenetic Biosciences reported Non Operating Income of $166,475, down 8.7% year-over-year; for FY2025, it was $153,722, down 37.0% from FY2024.

  • Non Operating Income carries a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
  • Going back by year, Non Operating Income was $244,153 in FY2024 (-35.9%), $381,137 in FY2023 (+130.2%), $165,555 in FY2022 (+63.0%) and $101,586 in FY2021 (-19.2%).
  • The five-year range for quarterly Non Operating Income is $14,889 (Q2 2022) to $147,225 (Q2 2023).
  • Year-over-year, Non Operating Income increased in two of the last eight quarters, with an average decline of 22.5%.
  • The fastest year-over-year change in Non Operating Income over five years came in Q2 2023 (growth of 888.8%), and the weakest in Q2 2024 (a decline of 56.9%).
  • Business Quant data shows XBIO's Non Operating Income at $45,735 (Q1 2026), $43,951 (Q4 2025) and $34,794 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Xenetic Biosciences 5.44 Mn -20.39 Mn - 41,995.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41,995.00
Mar 31, 2026 45,735.00
Dec 31, 2025 43,951.00
Sep 30, 2025 34,794.00
Jun 30, 2025 35,709.00
Mar 31, 2025 39,268.00
Dec 31, 2024 44,624.00
Sep 30, 2024 62,802.00
Jun 30, 2024 63,426.00
Mar 31, 2024 73,301.00
Dec 31, 2023 84,161.00
Sep 30, 2023 91,130.00
Jun 30, 2023 147,225.00
Mar 31, 2023 58,621.00
Dec 31, 2022 80,793.00
Sep 30, 2022 43,769.00
Jun 30, 2022 14,889.00
Mar 31, 2022 26,104.00
Dec 31, 2021 32,344.00
Sep 30, 2021 25,123.00
API Access

Xenetic Biosciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=XBIO&period=max&api_key=YOUR_API_KEY